Personalized Glaucoma Medication Compounding Reduces Intraocular Pressure and May Increase Adherence and Affordability

Abstract

We report results from four glaucoma patients on multiple topical medications who refused or failed interventional surgery and opted for in-office medication compounding (n=4). Topical medications with preservatives were compounded into one 10ml-bottle under sterile conditions. Patients used one drop of the compounded solution twice daily. Patients demonstrated significantly reduced IOP and self-reported better compliance after 3 months of use